Sponsor Pipeline

Zhejiang Yangli Pharmaceutical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06819215 Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid… Cancer Recruiting
Phase 1
NCT07254481 VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy… Hypertension Recruiting
Disease Areas
Breast Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Ovarian Cancer (1) Hypertension (1)
Get alerts when Zhejiang Yangli Pharmaceutical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free